Sarcoidosis — all decisions

The Board denied the Veteran's claim for service connection for sarcoidosis, finding no evidence of a medical nexus between the condition and his active service.

The Board denied the Veteran's claim for service connection for sarcoidosis, finding that the evidence did not support a causal relationship between the Veteran's current condition and his active service, including exposure to Agent Orange.

The Board remands the claims for service connection for various conditions due to an incomplete search of the Veteran's service records and a failure to verify reported in-service exposure to ionizing radiation.

The Board granted a 50 percent rating for the Veteran's service-connected asthma with sarcoidosis and obstructive sleep apnea, but denied an earlier effective date for the increased 30 percent rating for chronic sinusitis and remanded claims for service connection for left and right upper extremity disabilities.

The Board denied service connection for sarcoidosis as it was not shown in service, to a compensable degree within one year of service, or causally related to service.

The Board remands the issues of entitlement to service connection for the cause of the Veteran's death and Dependency and Indemity Compensation (DIC) due to a need for additional evidence.

The Board granted service connection for a headache disorder and sarcoidosis pursuant to the PACT Act, but remanded the claim for further development regarding other potential bases of service connection for sarcoidosis.

The Board granted service connection for sarcoidosis, finding that the Veteran's condition is related to his active service.

The Board granted an initial disability rating of 30 percent for service-connected sarcoidosis with chronic obstructive pulmonary disease, but denied a motion to revise the March 2021 rating decision based on clear and unmistakable error.

The Board granted an initial disability rating of 30 percent for service-connected sarcoidosis with chronic obstructive pulmonary disease, but denied a motion to revise the March 2021 rating decision based on clear and unmistakable error.

The Board granted an initial disability rating of 30 percent for service-connected sarcoidosis with chronic obstructive pulmonary disease, but denied a motion to revise the March 2021 rating decision based on clear and unmistakable error.

The Board granted an initial disability rating of 30 percent for service-connected sarcoidosis with chronic obstructive pulmonary disease, but denied a motion to revise the March 2021 rating decision based on clear and unmistakable error.

The Veteran's service connection for sarcoidosis was granted on a presumptive basis under the PACT Act, while his claim for asthma was denied.

The Board granted service connection for sarcoidosis and denied service connection for phimosis, diabetes mellitus, type II, eczema, bilateral plantar fasciitis, and right achilles tendinosis.

The Board remands the claims for a compensable disability rating for sarcoidosis and service connection for deep vein thrombosis (DVT) and pulmonary embolisms, as there is insufficient evidence of record to make a decision on these issues.